Testing next-generation sequencing in neutropenic sepsis
Part of Blood & lymphatic clinical trials.
This trial studies whether advanced genetic testing (next-generation sequencing) can help doctors better understand and manage neutropenic sepsis—a serious infection risk when white blood cell counts are too low. You may be considered if you develop fever or sepsis quickly (within 24 hours) while your counts are low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can give consent, or a suitable representative can if you cannot
- Your lab results show low neutrophils (ANC under 500) or, if ANC isn’t available, high enough to qualify as low white cells (WBC under 1000)
- You have fever or sepsis that started less than 24 hours ago
- This is your first qualifying episode during this hospital stay (not a second fever episode)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether proteins in your blood can predict complications when you have a fever and very low white blood cells after cancer treatment. It aims to help doctors choose the best antibiotics early on.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
This trial tests a new way to find infections (using a test called mNGS) that may be quicker and more accurate than standard tests. It is for people with blood cancers who show signs of a possible fungal infection, like fever or abnormal lung scans.
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
Hear when a new Febrile Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.